Clinical Trial Update: Phase III Clinical Trial of Hepalatide in Patients With Chronic Hepatitis D [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Hepalatide for chronic hepatitis D is not yet recruiting. The trial is sponsored by Shanghai HEP Pharmaceutical Co., Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis D

Drugs mentioned

• Hepalatide

Snippet

Sponsor: Shanghai HEP Pharmaceutical Co., Ltd. | Conditions: Hepatitis D, Chronic | Phase 3 | Status: NOT_YET_RECRUITING